Cite
Surface-anchored microbial enzyme-responsive solid lipid nanoparticles enabling colonic budesonide release for ulcerative colitis treatment.
MLA
Zhang, Yipeng, et al. “Surface-Anchored Microbial Enzyme-Responsive Solid Lipid Nanoparticles Enabling Colonic Budesonide Release for Ulcerative Colitis Treatment.” Journal of Nanobiotechnology, vol. 21, no. 1, May 2023, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s12951-023-01889-0.
APA
Zhang, Y., Wang, L., Wang, Z.-D., Zhou, Q., Zhou, X., Zhou, T., Guan, Y.-X., & Liu, X. (2023). Surface-anchored microbial enzyme-responsive solid lipid nanoparticles enabling colonic budesonide release for ulcerative colitis treatment. Journal of Nanobiotechnology, 21(1), 1–15. https://doi.org/10.1186/s12951-023-01889-0
Chicago
Zhang, Yipeng, Liying Wang, Zi-Dan Wang, Quan Zhou, Xuefei Zhou, Tianhua Zhou, Yi-Xin Guan, and Xiangrui Liu. 2023. “Surface-Anchored Microbial Enzyme-Responsive Solid Lipid Nanoparticles Enabling Colonic Budesonide Release for Ulcerative Colitis Treatment.” Journal of Nanobiotechnology 21 (1): 1–15. doi:10.1186/s12951-023-01889-0.